Ambar Protein Inds.
Ticker > Company >

Ambar Protein Inds. share price

Ambar Protein Industries Ltd.

  17.67 K   27   1 BSE: 519471 SECTOR: Edible Oil

190.95
+8.95 (4.92%)
BSE: 19 Oct 4:00 PM

Buy on Angel One

Price Summary

Today's High

₹ 190.95

Today's Low

₹ 190.95

52 Week High

₹ 327.5

52 Week Low

₹ 140

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 109.8 Cr.

Enterprise Value

₹ 134.55 Cr.

No. of Shares

0.58 Cr.

P/E

10.95

P/B

2.41

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  79.17

CASH

₹ 1.21 Cr.

DEBT

₹ 25.96 Cr.

Promoter Holding

73.87 %

EPS (TTM)

₹  17.45

Sales Growth

25.03%

ROE

32.28 %

ROCE

27.5%

Profit Growth

206.77 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year25.03%
3 Year7.46%
5 Year8.2%

Profit Growth

1 Year206.77%
3 Year29.46%
5 Year50.57%

ROE%

1 Year32.28%
3 Year19.79%
5 Year22.49%

ROCE %

1 Year27.5%
3 Year17.67%
5 Year17.57%

Debt/Equity

0.7475

Price to Cash Flow

50.54

Interest Cover Ratio

6.7466

CFO/PAT (5 Yr. Avg.)

0.591070539842696

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 73.87 0.00
Jun 2026 73.76 0.00
Mar 2026 72.69 0.00
Dec 2025 72.07 0.00
Sep 2025 71.48 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 29.4341895223194% for the Past 3 years.
  • Company’s PEG ratio is 0.0529353111786213.
  • The company has an efficient Cash Conversion Cycle of 27.3322 days.
  • The company has a high promoter holding of 73.87%.

 Limitations

  • The company has shown a poor revenue growth of 7.46212888040954% for the Past 3 years.
  • The company has a low EBITDA margin of 2.61445722951367% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 117.27 111.67 124.92 146.8 113.45
Total Expenditure 115.13 109.17 121.68 142.69 107.7
Operating Profit 2.15 2.5 3.24 4.12 5.75
Other Income 0.19 0.19 0.19 0.22 0.19
Interest 0.53 0.45 0.5 0.55 0.47
Depreciation 0.33 0.34 0.34 0.36 0.36
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.47 1.9 2.59 3.43 5.11
Tax 0.72 -0.1 0.77 0.97 1.36
Profit After Tax 0.75 2 1.81 2.46 3.75
Adjusted EPS (Rs) 1.3 3.48 3.15 4.29 6.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 313.3 339.75 345.08 337.23 421.62
Total Expenditure 305.94 330.56 337.87 329.84 405.85
Operating Profit 7.36 9.19 7.21 7.39 15.77
Other Income 0.47 0.69 0.56 0.5 0.84
Interest 2.64 2.69 2.53 2.46 2.27
Depreciation 1.2 1.28 1.28 1.31 1.31
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.98 5.91 3.96 4.12 13.03
Tax 0.53 1.46 1.15 0.97 3.38
Net Profit 3.45 4.45 2.83 3.15 9.65
Adjusted EPS (Rs.) 6 7.74 4.89 5.47 16.78

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 5.75 5.75 5.75 5.75 5.75
Total Reserves 8.9 13.35 16.18 19.32 28.98
Borrowings 3.58 2.7 1.73 0.44 0.16
Other N/C liabilities 3.4 3.14 3.16 2.33 2.37
Current liabilities 28.61 39.2 35.48 33.54 33.25
Total Liabilities 50.23 64.14 62.29 61.38 70.5
Assets
Net Block 21.14 20.55 20.01 19.33 18.41
Capital WIP 0.22 0 0.01 0 0.75
Intangible WIP 0 0 0 0 0
Investments 0.02 0.02 0.02 0.02 0.02
Loans & Advances 0.11 0.11 1.52 1.41 2.98
Other N/C Assets 0 0 0 0 0
Current Assets 28.74 43.46 40.74 40.62 48.34
Total Assets 50.23 64.14 62.29 61.38 70.5
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 3.98 5.91 3.96 4.12 13.03
Adjustment 3.86 3.56 3.33 3.29 2.75
Changes in Assets & Liabilities -6.02 -11.05 0.55 0.21 -10.97
Tax Paid -0.72 -0.95 -1.66 -0.65 -2.63
Operating Cash Flow 1.1 -2.53 6.18 6.97 2.17
Investing Cash Flow -0.01 -0.08 0.28 -0.15 -0.3
Financing Cash Flow -2.46 2.45 -6.24 -6.87 -1.81
Net Cash Flow -1.37 -0.16 0.23 -0.05 0.06

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Last Updated on:
Brief about Ambar Protein Inds.
X